Lymphadenectomy in papillary thyroid carcinoma (PTC) is controversial. It is indicated whenever metastases have been proven before or during surgery and as a prophylactic treatment in high-risk patients. However, 30–50% of cN0 patients become pN1 postoperatively. In PTC, selective-sentinel-lymph-node-biopsy (SLNB) with conventional intraoperative analysis is 8% false negative. One-step nucleic acid amplification (OSNA) is a molecular technique which allows real-time detection of mRNA encoding for cytokeratin 19. OSNA has been introduced in intraoperative analysis of several tumors to reduce false-negative rates and distinguish micrometastasis from macrometastasis. Our objective was to evaluate the impact of the introduction of OSNA in the intraoperative evaluation of the sentinel node (SN) in PTC.
We analyzed a series of 35 patients subjected to SLNB.
All the dissected nodes, SN and non-SN, were evaluated with OSNA and cytology.
We obtained a total of 110 SN. SLNB proved positive in 14 patients (40%) with cytology and in 23 (65.7%) with OSNA (P < 0.001). In the 29 patients with subsequent lymphadenectomy we obtained 360 lymph nodes ((52 positive in cytology (14.4%) and 107 in OSNA (29.7%)). Lymphadenectomy proved positive in 16 patients according to cytology (55%) and in 24 according to OSNA (83%) (P = 0002). The majority of patients with micrometastasis in SN showed only micrometastasis in lymphadenectomy.
The present study shows selective-sentinel-lymph-node-biopsy with one-step nucleic acid amplification technique to be feasible in papillary thyroid carcinoma. The quantitative nature of one-step nucleic acid amplification paves the way toward a more personalized surgical approach, limiting lymphadenectomy to patients with intraoperative evidence of macrometastasis in the sentinel node.
HaugenBRAlexanderEKBibleKCDohertyGMMandelSJNikiforovYEPaciniFRandolphGWSawkaAMSchlumbergerMet al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Annals of Surgery2016261–13. (https://doi.org/10.1089/thy.2015.0020)
HartlDMLeboulleuxSAl GhuzlanABaudinEChamiLSchlumbergerMTravagliJP.Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Annals of Surgery2012255777–783 (https://doi.org/10.1097/SLA.0b013e31824b7b68)
GonzálezÓZafonCCaubetEGarcía-BurilloASerresXFortJMMesaJCastellJRocaIRamón y CajalSet al. Selective sentinel lymph node biopsy in papillary thyroid carcinoma in patients with no preoperative evidence of lymph node metastasis. Endocrinology Diabetes and Nutrition201764451–455. (https://doi.org/10.1016/j.endinu.2017.05.001)
Garcia-BurilloARoca BielsaIGonzalezOZafonCSabateMCastellviJSerresXIglesiasCVilallongaRCaubetEet al. SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement. European Journal of Nuclear Medicine and Molecular Imaging2013401645–1655. (https://doi.org/10.1007/s00259-013-2476-x)
WongJYongWSThikeAAIqbalJSalahuddinASHoGHMadhukumarPTanBKOngKWTanPH.False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: a retrospective analysis of patients in a single Asian institution. Journal of Clinical Pathology201568536–540. (https://doi.org/10.1136/jclinpath-2014-202799)
MiyashiroIHiratsukaMSasakoMSanoTMizusawaJNakamuraKNashimotoATsuburayaAFukushimaN.High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer201417316–323. (https://doi.org/10.1007/s10120-013-0285-3)
SlamaJDundrPDusekLCibulaD.High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecologic Oncology2013129384–388. (https://doi.org/10.1016/j.ygyno.2013.02.001)
TsujimotoMNakabayashiKYoshidomeKKanekoTIwaseTAkiyamaFKatoYTsudaHUedaSSatoKet al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clinical Cancer Research2007134807–4816. (https://doi.org/10.1158/1078-0432.CCR-06-2512)
TamakiYAkiyamaFIwaseTKanekoTTsudaHSatoKUedaSManoMMasudaNTakedaMet al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clinical Cancer Research2009152879–2884. (https://doi.org/10.1158/1078-0432.CCR-08-1881)
del CarmenSGatiusSFranch-ArcasGBaenaJAGonzalezOZafonCCuevasDVallsJPérezAMartinezMet al. Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid. Human Pathology201648132–141. (https://doi.org/10.1016/j.humpath.2015.09.020)
López-RuizMEDiestroMDYébenesLBerjónADíaz de la NovalBMendiolaMDe SantiagoJHardissonD. One-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastasis in endometrial cancer. Gynecologic Oncology201614354–59. (https://doi.org/10.1016/j.ygyno.2016.07.106)
OkamotoSNiikuraHNakabayashiKHiyamaKMatodaMTakeshimaNWatanabeMNagaseSOtsukiTYaegashiN.Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method. Gynecologic Oncology2013130530–536. (https://doi.org/10.1016/j.ygyno.2013.06.027)
NakagawaKAsamuraHTsutaKNagaiKYamadaEIshiiGMitsudomiTItoAHigashiyamaMTomitaYet al. The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): results of a multicenter prospective study. Lung Cancer2016971–7. (https://doi.org/10.1016/j.lungcan.2016.03.015)
GüllerUZettlAWorniMLangerICabalzar-WondbergDViehlCTDemartinesNZuberM. Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?Cancer20161186039–6045. (https://doi.org/10.1002/cncr.27667)
KumagaiKYamamotoNMiyashiroITomitaYKataiHKushimaRTsudaHKitagawaYTakeuchiHMukaiMet al. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer201417273–280. (https://doi.org/10.1007/s10120-013-0271-9)
KaczkaKFendlerWBorowiecMMłynarskiWPomorskiL. First one-step nucleic acid amplification testing in papillary thyroid cancer lymph nodes – a comparison with histopathology and real-time PCR. Endokrynologia Polska201465422–430. (https://doi.org/10.5603/EP.2014.0059)
CserniGAmendoeiraIApostolikasNBellocqJPBianchiSBussolatiGBoeckerWBorischBConnollyCEDeckerTet al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. European Journal of Cancer2003391654–1667. (https://doi.org/10.1016/S0959-8049(03)00203-X)
PegVEspinosa-BravoMVieitesBVilardellFAntúnezJRde SalasMSDelgado-SánchezJJPintoWGozalboFPetitAet al. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients. Breast Cancer Research and Treatment201313987–93. (https://doi.org/10.1007/s10549-013-2524-z)
Di FilippoFGiannarelliDBouteilleCBernetLCanoRCunnickGSapinoA. Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method. Journal of Experimental and Clinical Cancer Research201534136. (https://doi.org/10.1186/s13046-015-0246-2)
PiñeroAGiménezJMerckBVázquezC.Consensus meeting on selective biopsy of the sentinel node in breast cancer. Spanish Society of Senology and Breast Disease. Revista Española de Medicina Nuclear200726176–180.